91 related articles for article (PubMed ID: 21224710)
1. [Microdochectomy for elderly patient of ductal carcinoma in situ].
Sakurai K; Enomoto K; Amano S
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2778-80. PubMed ID: 21224710
[TBL] [Abstract][Full Text] [Related]
2. [Successful treatment of neuroendocrine ductal carcinoma in situ with loco-regional therapy].
Sakurai K; Fujisaki S; Maeda T; Nagashima S; Hara Y; Tomita R; Suzuki S; Hirano T; Enomoto K; Amano S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2363-5. PubMed ID: 24394113
[TBL] [Abstract][Full Text] [Related]
3. [Treatment strategy of breast carcinoma in the elderly patient-surgery, hormone therapy, and chemotherapy].
Sakurai K; Fujisaki S; Matsuo S; Ogura M; Enomoto K; Kitajima A; Tani M; Amano S; Shiono M
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2105-7. PubMed ID: 20037338
[TBL] [Abstract][Full Text] [Related]
4. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
Ringberg A; Andersson I; Aspegren K; Linell F
Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
[TBL] [Abstract][Full Text] [Related]
5. [Surgical resection for elderly patient with skin invasion of breast cancer].
Suzuki S; Sakurai K; Nagashima S; Fujisaki S; Shibata M; Tomita R; Hara Y; Matsumoto K; Enomoto K; Amano S
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2011-3. PubMed ID: 22202268
[TBL] [Abstract][Full Text] [Related]
6. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
[TBL] [Abstract][Full Text] [Related]
7. Microdochectomy in the management of pathologic nipple discharge.
Fajdić J; Gotovac N; Glavić Z; Hrgović Z; Jonat W; Schem C
Arch Gynecol Obstet; 2011 Apr; 283(4):851-4. PubMed ID: 20458490
[TBL] [Abstract][Full Text] [Related]
8. Influence of local treatment on the recurrence rate of ductal carcinoma in situ.
Warneke J; Grossklaus D; Davis J; Stea B; Bebb G; Taylor C; Hastings R; Villar H
J Am Coll Surg; 1995 Jun; 180(6):683-8. PubMed ID: 7773481
[TBL] [Abstract][Full Text] [Related]
9. Recurrence after breast ablation for ductal carcinoma in situ.
de Jong E; Peterse JL; van Dongen JA
Eur J Surg Oncol; 1992 Feb; 18(1):64-6. PubMed ID: 1310646
[TBL] [Abstract][Full Text] [Related]
10. Current management of ductal carcinoma in situ.
Barth A; Brenner RJ; Giuliano AE
West J Med; 1995 Oct; 163(4):360-6. PubMed ID: 7483593
[TBL] [Abstract][Full Text] [Related]
11. In situ ductal carcinoma of the breast--analysis of clinical presentation and outcome in 156 consecutive cases.
Ciatto S; Grazzini G; Iossa A; Del Turco MR; Bravetti P; Cataliotti L; Cardona G; Bianchi S
Eur J Surg Oncol; 1990 Jun; 16(3):220-4. PubMed ID: 2161353
[TBL] [Abstract][Full Text] [Related]
12. The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P
Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of ductal carcinoma in situ with interruption of the anterior border of the mammary gland by ultrasonography-a case report].
Sakurai K; Fujisaki S; Maeda T; Nagashima S; Hara Y; Tomita R; Suzuki S; Enomoto K; Amano S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2360-2. PubMed ID: 24394112
[TBL] [Abstract][Full Text] [Related]
14. Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge.
Liu GY; Lu JS; Shen KW; Wu J; Chen CM; Hu Z; Shen ZZ; Zhang TQ; Shao ZM
Breast Cancer Res Treat; 2008 Mar; 108(2):271-7. PubMed ID: 17473979
[TBL] [Abstract][Full Text] [Related]
15. Breast disease: a primer on diagnosis and management.
Drukker BH
Int J Fertil Womens Med; 1997; 42(5):278-87. PubMed ID: 9406832
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
17. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
18. p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast.
de Roos MA; de Bock GH; de Vries J; van der Vegt B; Wesseling J
J Surg Res; 2007 Jun; 140(1):109-14. PubMed ID: 17291532
[TBL] [Abstract][Full Text] [Related]
19. Mastectomy without malignancy after carcinoma diagnosed by large-core stereotactic breast biopsy.
Casey M; Rosenblatt R; Zimmerman J; Fineberg S
Mod Pathol; 1997 Dec; 10(12):1209-13. PubMed ID: 9436965
[TBL] [Abstract][Full Text] [Related]
20. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
